Perturbations of a causal synaptic molecular network in autism and schizophrenia revealed with multiplexed imaging

The complex functions of neuronal synapses in the central nervous system depend on their tightly interacting, compartmentalized molecular network of hundreds of proteins spanning the pre- and post-synaptic sites. This biochemical system is implicated in the pathogenesis of autism spectrum disorders and schizophrenia, with identified common synaptopathologies and numerous risk genes associated with synaptic function. However, it remains unclear how the synaptic molecular network is altered in these disorders, and whether effects are common to distinct genetic perturbations. Here, we applied PRISM, a quantitative single-synapse multiplexed imaging technique, to systematically probe the effects of RNAi knockdown of 16 autism- and schizophrenia-associated genes on the simultaneous distribution of 10 synaptic proteins. This enabled the identification of novel phenotypes in synapse compositions and distributions. We applied Bayesian network inference to construct and validate a predictive model of causal hierarchical dependencies among eight proteins of the excitatory synapse. The resulting conditional dependence relationships could only be accessed via measurement which is both single-synapse and multiprotein, unique to PRISM. Finally, we show that central features of the network are similarly affected across distinct gene knockdowns. These results offer insight into the convergent molecular etiology of these debilitating, hereditary and highly polygenic disorders, as well as offering a novel, general framework for probing subcellular molecular networks.

[1]  S. Gabriel,et al.  Rare coding variants in ten genes confer substantial risk for schizophrenia , 2022, Nature.

[2]  A. Koleske,et al.  Control of Synapse Structure and Function by Actin and Its Regulators , 2022, Cells.

[3]  Iain G. Johnston,et al.  Symmetry and simplicity spontaneously emerge from the algorithmic nature of evolution , 2021, bioRxiv.

[4]  Anne E Carpenter,et al.  CellProfiler 4: improvements in speed, utility and usability , 2021, BMC Bioinformatics.

[5]  Staci A. Sorensen,et al.  Local Connectivity and Synaptic Dynamics in Mouse and Human Neocortex , 2021, bioRxiv.

[6]  Anne E Carpenter,et al.  Resolving cell state in iPSC-derived human neural samples with multiplexed fluorescence imaging , 2021, Communications biology.

[7]  E. Castrén,et al.  Antidepressant drugs act by directly binding to TRKB neurotrophin receptors , 2019, Cell.

[8]  Alan C. Evans,et al.  Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia , 2020, Nature Communications.

[9]  Anne E Carpenter,et al.  Molecular Diversity of Glutamatergic and GABAergic Synapses from Multiplexed Fluorescence Imaging , 2020, eNeuro.

[10]  Laura C. Andreae,et al.  Cell-type-specific synaptic imbalance and disrupted homeostatic plasticity in cortical circuits of ASD-associated Chd8 haploinsufficient mice , 2020, bioRxiv.

[11]  E. Castrén,et al.  Pharmacologically diverse antidepressants facilitate TRKB receptor activation by disrupting its interaction with the endocytic adaptor complex AP-2 , 2019, The Journal of Biological Chemistry.

[12]  Li Li,et al.  Multiplexed and high-throughput neuronal fluorescence imaging with diffusible probes , 2019, Nature Communications.

[13]  Roy Ben-Shalom,et al.  The Autism-Associated Gene Scn2a Contributes to Dendritic Excitability and Synaptic Function in the Prefrontal Cortex , 2019, Neuron.

[14]  J. Peça,et al.  New insights on synaptic dysfunction in neuropsychiatric disorders , 2019, Current Opinion in Neurobiology.

[15]  G. Gilmour,et al.  Targeting the Synapse in Alzheimer’s Disease , 2019, Front. Neurosci..

[16]  D. Feldman,et al.  Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models , 2018, Neuron.

[17]  F. Yin,et al.  Synaptopathology Involved in Autism Spectrum Disorder , 2018, Front. Cell. Neurosci..

[18]  Chiara Nicolini,et al.  Clustering the autisms using glutamate synapse protein interaction networks from cortical and hippocampal tissue of seven mouse models , 2018, Molecular Autism.

[19]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..

[20]  E. Fransén,et al.  Architecture of the Mouse Brain Synaptome , 2018, Neuron.

[21]  Kaare Christensen,et al.  Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register , 2017, Biological Psychiatry.

[22]  Heather C. Mefford,et al.  Clinical phenotype of ASD-associated DYRK1A haploinsufficiency , 2017, Molecular Autism.

[23]  J. Krystal,et al.  Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders , 2017, Biological Psychiatry.

[24]  R. Canitano,et al.  Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories , 2017, Front. Psychiatry.

[25]  Zhengwei Li,et al.  A liminal stage after predictive testing for Huntington disease , 2017, Journal of Medical Genetics.

[26]  G. Martinotti,et al.  Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions , 2017, International journal of molecular sciences.

[27]  D. Geschwind,et al.  Advancing the understanding of autism disease mechanisms through genetics , 2016, Nature Medicine.

[28]  C. Claudianos,et al.  Genetic heterogeneity in autism: From single gene to a pathway perspective , 2016, Neuroscience & Biobehavioral Reviews.

[29]  G. Aghajanian,et al.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants , 2016, Nature Medicine.

[30]  C. Garner,et al.  Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone , 2016, Front. Synaptic Neurosci..

[31]  P. Bolton,et al.  Heritability of autism spectrum disorders: a meta‐analysis of twin studies , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[32]  Kali T. Witherspoon,et al.  Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID , 2016, Molecular Psychiatry.

[33]  R. Nicoll,et al.  PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density , 2015, Proceedings of the National Academy of Sciences.

[34]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[35]  S. Bookheimer,et al.  Neurobiology of Sensory Overresponsivity in Youth With Autism Spectrum Disorders. , 2015, JAMA psychiatry.

[36]  Matthew W State,et al.  Autism spectrum disorders: from genes to neurobiology , 2015, Current Opinion in Neurobiology.

[37]  Robert Freedman,et al.  Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. , 2015, The American journal of psychiatry.

[38]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[39]  R. Held,et al.  Autism as a disorder of prediction , 2014, Proceedings of the National Academy of Sciences.

[40]  Shun-ying Yu,et al.  Synaptic proteins and receptors defects in autism spectrum disorders , 2014, Front. Cell. Neurosci..

[41]  Y. Yanagawa,et al.  Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage , 2014, Neurobiology of Disease.

[42]  J. Fritschy,et al.  Gephyrin: a master regulator of neuronal function? , 2014, Nature Reviews Neuroscience.

[43]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[44]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[45]  P. Golshani,et al.  PTEN: A master regulator of neuronal structure, function, and plasticity. , 2014, Communicative & integrative biology.

[46]  Sharmila Banerjee-Basu,et al.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.

[47]  L. Siever,et al.  Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.

[48]  N. de Lacy,et al.  Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology. , 2013, Annual review of clinical psychology.

[49]  Nanxin Li,et al.  A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[50]  Guoping Feng,et al.  Cellular and synaptic network defects in autism , 2012, Current Opinion in Neurobiology.

[51]  Mark F Bear,et al.  Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. , 2012, Cold Spring Harbor perspectives in biology.

[52]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[53]  V. Menon Large-scale brain networks and psychopathology: a unifying triple network model , 2011, Trends in Cognitive Sciences.

[54]  M. Chiappalone,et al.  Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses , 2011, The Journal of Biological Chemistry.

[55]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[56]  Diana V. Dugas,et al.  Protein Interactome Reveals Converging Molecular Pathways Among Autism Disorders , 2011, Science Translational Medicine.

[57]  Inge-Marie Eigsti,et al.  Language acquisition in autism spectrum disorders: A developmental review. , 2011 .

[58]  P. Penzes,et al.  Dendritic spine pathology in neuropsychiatric disorders , 2011, Nature Neuroscience.

[59]  S. Grant,et al.  Characterization of the proteome, diseases and evolution of the human postsynaptic density , 2011, Nature Neuroscience.

[60]  A. Packer,et al.  SFARI Gene: an evolving database for the autism research community , 2010, Disease Models & Mechanisms.

[61]  J. Matson,et al.  Intellectual disability and its relationship to autism spectrum disorders. , 2009, Research in developmental disabilities.

[62]  M. Owen,et al.  Genetic overlap between autism, schizophrenia and bipolar disorder , 2009, Genome Medicine.

[63]  Marco Scutari,et al.  Learning Bayesian Networks with the bnlearn R Package , 2009, 0908.3817.

[64]  D. Owald,et al.  Assembling the presynaptic active zone , 2009, Current Opinion in Neurobiology.

[65]  S. Grant,et al.  Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins , 2009, Molecular systems biology.

[66]  Thomas Bourgeron,et al.  A synaptic trek to autism , 2009, Current Opinion in Neurobiology.

[67]  R. Nicoll,et al.  Silent synapses and the emergence of a postsynaptic mechanism for LTP , 2008, Nature Reviews Neuroscience.

[68]  A. Jablensky,et al.  Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study , 2008, British Journal of Psychiatry.

[69]  Y. Goda,et al.  Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy , 2008, Nature Reviews Neuroscience.

[70]  J. Vessey,et al.  More than just synaptic building blocks: scaffolding proteins of the post‐synaptic density regulate dendritic patterning , 2007, Journal of neurochemistry.

[71]  T. Soderling,et al.  Regulatory mechanisms of AMPA receptors in synaptic plasticity , 2007, Nature Reviews Neuroscience.

[72]  I. Ebert‐Uphoff Measuring Connection Strengths and Link Strengths in Discrete Bayesian Networks , 2007 .

[73]  Darren J. Wilkinson,et al.  Bayesian methods in bioinformatics and computational systems biology , 2006, Briefings Bioinform..

[74]  S. Grant,et al.  The synapse proteome and phosphoproteome: a new paradigm for synapse biology. , 2006, Biochemical Society transactions.

[75]  A. Fanous,et al.  Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework , 2006, Molecular Psychiatry.

[76]  D. Pe’er Bayesian Network Analysis of Signaling Networks: A Primer , 2005, Science's STKE.

[77]  K. Sachs,et al.  Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data , 2005, Science.

[78]  Paul P. Wang,et al.  Advances to Bayesian network inference for generating causal networks from observational biological data , 2004, Bioinform..

[79]  M. Bennett,et al.  Postsynaptic Density Protein-95 Regulates NMDA Channel Gating and Surface Expression , 2004, The Journal of Neuroscience.

[80]  Seth G N Grant,et al.  Synapse signalling complexes and networks: machines underlying cognition. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[81]  S. Grant,et al.  Proteomic analysis of NMDA receptor–adhesion protein signaling complexes , 2000, Nature Neuroscience.

[82]  Ann Marie Craig,et al.  Activity Regulates the Synaptic Localization of the NMDA Receptor in Hippocampal Neurons , 1997, Neuron.

[83]  M. Bate,et al.  Presynaptic Development at the Drosophila Neuromuscular Junction: Assembly and Localization of Presynaptic Active Zones , 1996, Neuron.

[84]  L. Schreibman Diagnostic Features of Autism , 1988, Journal of child neurology.

[85]  M. Geyer,et al.  Startle habituation and sensorimotor gating in schizophrenia and related animal models. , 1987, Schizophrenia bulletin.

[86]  B. Prizant,et al.  Language acquisition and communicative behavior in autism: toward an understanding of the "whole" of it. , 1983, The Journal of speech and hearing disorders.